Condensed Consolidated Statements of Equity - USD ($) $ in Thousands		Total	Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interests in Subsidiaries
Common stock, outstanding, beginning balance (in shares) at Dec. 29, 2019				168,121,000
Stockholders' equity, beginning of period at Dec. 29, 2019		$ 21,499	$ 10,163	$ 168	$ 2,661,819	$ (192,633)	$ (9,512)	$ (2,449,679)	$ 11,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(2,138)	(1,431)					(1,431)	(707)
Other comprehensive income (loss)		723	723				723
Issuance of restricted stock to employees, net of cancellations (in shares)				2,452,000
Issuance of restricted stock to employees, net of cancellations		3	3	$ 3
Stock-based compensation expense		6,885	6,885		6,885
Purchases of treasury stock (in shares)				(818,000)
Purchases of treasury stock		(6,911)	(6,911)	$ (1)		(6,910)
Common stock, outstanding, ending balance (in shares) at Mar. 29, 2020				169,755,000
Stockholders' equity, end of period at Mar. 29, 2020		20,061	9,432	$ 170	2,668,704	(199,543)	(8,789)	(2,451,110)	10,629
Common stock, outstanding, beginning balance (in shares) at Dec. 29, 2019				168,121,000
Stockholders' equity, beginning of period at Dec. 29, 2019		21,499	10,163	$ 168	2,661,819	(192,633)	(9,512)	(2,449,679)	11,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)		(853)
Common stock, outstanding, ending balance (in shares) at Jun. 28, 2020				170,059,000
Stockholders' equity, end of period at Jun. 28, 2020		41,305	31,656	$ 170	2,674,379	(200,796)	(10,365)	(2,431,732)	9,649
Common stock, outstanding, beginning balance (in shares) at Mar. 29, 2020				169,755,000
Stockholders' equity, beginning of period at Mar. 29, 2020		20,061	9,432	$ 170	2,668,704	(199,543)	(8,789)	(2,451,110)	10,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		18,398	19,378					19,378	(980)
Other comprehensive income (loss)		(1,576)	(1,576)				(1,576)
Issuance of restricted stock to employees, net of cancellations (in shares)				533,000
Stock-based compensation expense		5,675	5,675		5,675
Purchases of treasury stock (in shares)				(229,000)
Purchases of treasury stock		(1,253)	(1,253)			(1,253)
Common stock, outstanding, ending balance (in shares) at Jun. 28, 2020				170,059,000
Stockholders' equity, end of period at Jun. 28, 2020		$ 41,305	31,656	$ 170	2,674,379	(200,796)	(10,365)	(2,431,732)	9,649
Common stock, outstanding, beginning balance (in shares) at Jan. 03, 2021		170,428,000		170,428,000
Stockholders' equity, beginning of period at Jan. 03, 2021		$ 406,486	404,167	$ 170	2,685,920	(205,476)	8,799	(2,085,246)	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(49,498)	(48,385)					(48,385)	(1,113)
Other comprehensive income (loss)		98	98				98
Issuance of restricted stock to employees, net of cancellations (in shares)				1,908,000
Issuance of restricted stock to employees, net of cancellations		2	2	$ 2
Stock-based compensation expense	[1]	5,437	5,437		5,437
Bond/debentures conversion (in shares)				4,000
Bond/debentures conversion		155	155		155
Purchases of treasury stock (in shares)				(76,000)
Purchases of treasury stock		(2,120)	(2,120)			(2,120)
Other adjustments		303	303		(89)			392
Common stock, outstanding, ending balance (in shares) at Apr. 04, 2021				172,264,000
Stockholders' equity, end of period at Apr. 04, 2021		$ 360,863	359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Common stock, outstanding, beginning balance (in shares) at Jan. 03, 2021		170,428,000		170,428,000
Stockholders' equity, beginning of period at Jan. 03, 2021		$ 406,486	404,167	$ 170	2,685,920	(205,476)	8,799	(2,085,246)	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)		$ 590
Common stock, outstanding, ending balance (in shares) at Jul. 04, 2021		172,842,000		172,842,000
Stockholders' equity, end of period at Jul. 04, 2021		$ 444,013	443,245	$ 172	2,703,647	(211,931)	9,389	(2,058,032)	768
Common stock, outstanding, beginning balance (in shares) at Apr. 04, 2021				172,264,000
Stockholders' equity, beginning of period at Apr. 04, 2021		360,863	359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		74,769	75,207					75,207	(438)
Other comprehensive income (loss)		492	492				492
Issuance of restricted stock to employees, net of cancellations (in shares)				664,000
Issuance of common stock to executive (in shares)	[2]			101,000
Issuance of common stock to executive	[2]	2,999	2,999		2,999
Stock-based compensation expense	[1]	9,225	9,225		9,225
Purchases of treasury stock (in shares)				(187,000)
Purchases of treasury stock		(4,310)	(4,310)			(4,310)
Other adjustments		$ (25)	(25)			(25)
Common stock, outstanding, ending balance (in shares) at Jul. 04, 2021		172,842,000		172,842,000
Stockholders' equity, end of period at Jul. 04, 2021		$ 444,013	$ 443,245	$ 172	$ 2,703,647	$ (211,931)	$ 9,389	$ (2,058,032)	$ 768

[1] Stock-based compensation expense includes a recharge to Maxeon Solar of $0.8 million and $0.4 million for the three and six months ended July 4, 2021, respectively, under the collaboration agreement (see Note 11. Related-Party Transactions).

[2] Refer to Note 11. Related-Party Transactions for details.